Dr. Maximilian Stahl, MD
Claim this profileDana-Farber Cancer Institute
Area of expertise
Acute Myelogenous Leukemia
Maximilian Stahl, MD has run 3 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Maximilian Stahl, MD has run 3 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Dana Farber Cancer Institute
Brigham And Women's Hospital
Clinical Trials Maximilian Stahl, MD is currently running
CIML NK Cells + Venetoclax
for Acute Myeloid Leukemia
The purpose of this research study is to test the safety and to explore the effectiveness of infusing cytokine- induced memory-like (CIML) natural killer (NK) cells in combination with Interleukin-2 (IL-2) and standard-of-care venetoclax as a treatment for Acute Myeloid Leukemia (AML). Names of the study therapies involved in this study are: * Lymphodepleting therapy with Fludarabine and Cyclophosphamide prior to CIML NK cell infusion * CIML NK (a cellular therapy) * IL-2 (a recombinant, human glycoprotein) * Venetoclax (a selective inhibitor of BCL-2 protein)
Recruiting
1 award
Phase 1
26 criteria
Revumenib + Standard Treatments
for Acute Myeloid Leukemia
This research is being conducted to determine a safe and effective dose of revumenib that can be given in combination with standard induction (initial therapy to induce a remission) + FLT3 targeted therapy (midostaurin) and a single cycle of post-remission therapy + FLT3 targeted therapy (midostaurin) to participants with newly diagnosed Nucleophosmin (NPM1) and FMS-like tyrosine kinase 3 (FLT3) mutated Acute Myeloid Leukemia (AML). The names of the study drugs involved in this study are: * Revumenib (SNDX-5613) (a type of menin inhibitor) * Midostaurin (a type of multi-kinase including FLT3 inhibitor) * Cytarabine (a type of antineoplastic agent) * Daunorubicin (a type of antineoplastic agent)
Recruiting
1 award
Phase 1
More about Maximilian Stahl, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Maximilian Stahl, MD has experience with
- SL-172154
- Cytokine-Induced Memory-like Natural Killer Cells
- Interleukin-2
- Venetoclax
- Cytarabine
- Daunorubicin
Breakdown of trials Maximilian Stahl, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Leukemia
Myelodysplastic Syndrome
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maximilian Stahl, MD specialize in?
Maximilian Stahl, MD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved TP53 positive patients, or patients who are NPM1 positive.
Is Maximilian Stahl, MD currently recruiting for clinical trials?
Yes, Maximilian Stahl, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Maximilian Stahl, MD has studied deeply?
Yes, Maximilian Stahl, MD has studied treatments such as SL-172154, Cytokine-Induced Memory-like Natural Killer Cells, Interleukin-2.
What is the best way to schedule an appointment with Maximilian Stahl, MD?
Apply for one of the trials that Maximilian Stahl, MD is conducting.
What is the office address of Maximilian Stahl, MD?
The office of Maximilian Stahl, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.